EVERSPIN TECHNOLOGIES INC. Quarterly Report Released - Here’s What You Should Know

Everspin Technologies, Inc. Quarterly Report Summary
For the Period Ended June 30, 2025

Key Financial Metrics

• Revenue for Q2 2025 was $13.2 million, up 24.1% from $10.6 million in Q2 2024.
• For the first half of 2025, revenue was $26.3 million, a 5.1% increase from $25.1 million in the prior-year period.
• Q2 2025 net loss was $0.7 million versus $2.5 million in Q2 2024. Six-month net loss was $1.8 million compared to $2.7 million in the prior year.
• Adjusted net income for Q2 2025 was $0.75 million (Q2 2024: $(0.64) million). Adjusted net income for the first half was $1.16 million (H1 2024: $0.87 million).
• Gross margin improved to 51.3% in Q2 2025 from 49.0% in Q2 2024; gross margin for the first half was 51.3%, down from 53.4% in 2024.
• Operating expenses increased to $8.7 million in Q2 2025 from $8.0 million in Q2 2024; for the first half, operating expenses were $17.4 million (H1 2024: $16.8 million).
• Cash and cash equivalents at June 30, 2025, were $45.0 million (December 31, 2024: $42.1 million).
• Positive cash flow from operations: $6.5 million for the six months ended June 30, 2025 (H1 2024: $0.4 million).
• Share count: 22,570,591 as of June 30, 2025.

Business Overview Everspin is a leader in Magnetoresistive Random Access Memory (MRAM) solutions, selling products directly and through distributors to OEMs and ODMs globally. The company uses both in-house and third-party manufacturing, serving customers in the APAC, North America, and EMEA regions.

Performance Drivers and Management Discussion

• Product sales drove most of the revenue, contributing $11.1 million in Q2 2025 (up 12.2% YoY); licensing, royalty, patent, and other revenues were $2.1 million (up 181.7% YoY).
• Q2 revenue growth was attributed to stronger distributor sales (66% of Q2 revenue) and increased licensing and patent-related revenue.
• APAC remains the largest region ($8.6 million in Q2), with solid growth followed by North America ($2.9 million) and EMEA ($1.7 million).
• Gross profit rose due to both higher volumes and a greater share of high-margin licensing/patent fees, partially offset by increased cost of goods sold.
• Operating expenses increased mainly due to higher general and administrative costs (+$0.4 million YoY in Q2) and sales and marketing investments (+$0.2 million YoY in Q2).
• Research and development expenses were flat as a percent of revenue, with minor absolute growth ($3.6 million in Q2).
• Other income for Q2 increased significantly ($0.8 million gain versus $30,000 loss in Q2 2024) due to a $1.0 million strategic award received for manufacturing and process development.

Risks and Uncertainties Highlighted

• Customer concentration: Revenue remains dependent on a few customers; for example, Customer C represented 26% of revenue in Q2, while Customers A and D each made up 14-20%. This creates risk should any large customer delay or reduce orders.
• Revenue volatility: Licensing, royalty, patent, and other revenues are subject to variability and hinge on a small number of contracts and awards. These streams are less predictable than product sales.
• Supply chain and inventory: Inventory grew from $9.1 million at year-end to $11.3 million at June 30, 2025. The company continues to balance inventory investments to support sales growth while avoiding excess or obsolete stock.
• Operating leverage: The company’s operating expenses have risen, particularly in administrative and sales functions, which could pressure margins if revenue growth does not continue.
• No material legal proceedings reported as of the filing.
• Capital investment: The company increased spending on property, equipment, and internally developed software this period ($2.9 million and $1.0 million, respectively), which may pressure cash if not carefully managed.

Liquidity and Capital Resources

• Liquidity remains strong with $45.0 million in cash and equivalents; the increase is due to strong operating cash flow.
• No debt outside of lease and software liabilities; total liabilities were $14.8 million vs. $64.1 million in stockholders’ equity at quarter-end.

Conclusion for Investors Everspin delivered strong top-line growth and significant improvement in bottom-line performance year-over-year, with notable gains in adjusted net income and gross margin. The business remains exposed to customer concentration and variability in non-product revenue but is well capitalized and investing for future growth. Investors should monitor customer mix, expense discipline, and long-term success in product commercialization and technology licensing.

Visit Publicview AI to search and analyze millions of SEC filings using AI.